Morphosys AG ADR (MOR): These Numbers Show Where NASDAQ:MOR Stock Is Going Next

Morphosys AG ADR (NASDAQ: MOR) is 73.23% higher on its value in year-to-date trading and has touched a low of $3.65 and a high of $17.87 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The MOR stock was last observed hovering at around $17.15 in the last trading session, with the day’s loss setting it 0.0%.

Currently trading at $17.15, the stock is 48.98% and 74.76% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.04 million and changing 0.00% at the moment leaves the stock 121.42% off its SMA200. MOR registered 243.00% gain for a year compared to 6-month gain of 127.45%. The firm has a 50-day simple moving average (SMA 50) of $8.34 and a 200-day simple moving average (SMA200) of $32.51.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

The stock witnessed a 83.82% loss in the last 1 month and extending the period to 3 months gives it a 107.63%, and is 54.92% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.32% over the week and 9.64% over the month.

Current P/E ratio is 30.13. Profit margin for the company is 28.04%. Distance from 52-week low is 369.86% and -4.03% from its 52-week high. The company has generated returns on investments over the last 12 months (34.85%).

Morphosys AG ADR quarterly earnings per share for the current quarter are estimated at $0.09 with sales reaching $66.76M over the same period.The EPS is expected to shrink by -87.95% this year, but quarterly earnings will post -11.50% year-over-year. Quarterly sales are estimated to shrink -24.40% in year-over-year returns.

Morphosys AG ADR (MOR) Top Institutional Holders

56 institutions hold shares in Morphosys AG ADR (MOR), with institutional investors hold 11.07% of the company’s shares. The shares outstanding are 150.38M, and float is at 149.93M with Short Float at 0.91%. Institutions hold 11.07% of the Float.

The top institutional shareholder in the company is T. Rowe Price Investment Management, Inc. with over 7.76 million shares valued at $57.97 million. The investor’s holdings represent 5.67% of the MOR Shares outstanding. As of Jun 29, 2023, the second largest holder is Logos Global Management LP with 1.2 million shares valued at $8.96 million to account for 0.88% of the shares outstanding. The other top investors are Opaleye Management Inc. which holds 1.21 million shares representing 0.88% and valued at over $9.03 million, while Hudson Bay Capital Management Lp holds 0.44% of the shares totaling 0.6 million with a market value of $4.46 million.